News Articles

  • University of Iowa Holden Comprehensive Cancer Center is the first U.S. cancer center to be designated a Neuroendocrine Tumor Center of Excellence by the European Neuroendocrine Tumor Society (ENETS). Read more
  • Researchers led by Holden Comprehensive Cancer Center member Miles Pufall, PhD, have identified a new target that may help improve treatment for children with relapsed B-cell acute lymphoblastic leukemia (B-ALL), the most common type of childhood cancer. Read more
  • This year’s Cancer in Iowa report, released March 5 by the UI-based State Health Registry of Iowa, outlines the growing threat of HPV-related cancers, the steady increase of cases among Iowa men, and the state’s performance in getting teens vaccinated for HPV. Read more
  • “We asked our current and past patients for their input, and their generous feedback allowed us to create this beautiful new unit that we can truly call patient-centered,” says Margarita Magalhaes-Silverman, MD, director of the UI Blood and Marrow Transplant Program. Read more
  • University of Iowa Holden Comprehensive Cancer Center and the Iowa State University College of Veterinary Medicine Oncology Program are collaborating to conduct cancer research focused on how similarities in cancers in both humans and companion animals can contribute to furthering research in both areas. Read more
  • To mark National Breast Cancer Awareness month, UI Health Care’s Breast Imaging Center features walk-in mammography screenings and complimentary parking during October. Read more
  • University of Iowa Hospitals & Clinics has again been named one of America’s “Best Hospitals” and the top hospital in Iowa, according to 2018-19 rankings released by U.S. News & World Report. Read more
  • UI radiation oncologist Carryn Anderson, MD, has been honored by the Multinational Association of Supportive Care in Cancer for research on a drug designed to alleviate oral mucositis, a common and debilitating side effect of head and neck chemoradiation treatments. Read more
  • University of Iowa Holden Comprehensive Cancer Center is the first provider in Iowa to offer CAR T-cell therapy, a groundbreaking treatment that uses a genetically improved version of a cancer patient’s own white blood cells to kill cancer cells. Read more
  • Sarcoma patients treated at high-volume medical centers may have higher survival rates than those treated at low-volume centers, according to a new analysis of cancer-treatment data by a team of University of Iowa researchers. Read more

Pages